Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ACRT about to move to new highs -- Ignore unavailable to you. Want to Upgrade?

To: Jonathan Cleveland who wrote (1914)	3/1/1998 8:16:00 PM
From: Andrew Q. Viet	Respond to of 7054

NASI is fundamentally sound, they have I-125 to treat prostate cancer.I think the CEO, Michael Cuttre, has a PhD in Physics, he was a professor at Stanford before founding NASI. He is very trust worthy, I talked to him on several occasions. The stock shot up a lot because it made the transition from BB to NMS listing and recently upgraded by Oppenheimer, and some other firms. But I think it's ahead of itself. but who knows, they do have a cure for prostate cancer and there are about 3 millions shares outstanding.